Ocugen Inc (NQ: OCGN )
1.395
+0.055
(+4.10%)
Streaming Delayed Price
Updated: 10:05 AM EDT, Jun 18, 2024
Add to My Watchlist
Headline News about Ocugen Inc
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine-2.jpg)
![](https://g.foolcdn.com/editorial/images/636342/people-crowding-around-a-computer.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/06/covid-1600.jpg)
![](https://g.foolcdn.com/editorial/images/635213/child-getting-a-jab-from-a-medical-professional.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_247.png)
![](https://g.foolcdn.com/editorial/images/634214/gettyimages-1296010642.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/syringe-866550_1920_1_18.jpg)
![](https://g.foolcdn.com/editorial/images/633563/covid-19-vaccine-montage.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-min.jpg)
![](https://g.foolcdn.com/editorial/images/633252/gettyimages-1298099807.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/syringe-1884758_1920_93.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-1.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_918.png)
Ocugen Preps US Filings For COVID-19 Vaccine As New Data Shows Overall Efficacy Of Around 79%
July 06, 2021
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_399.png)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-2.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine.jpg)
![](https://g.foolcdn.com/editorial/images/632362/3_tips_for_coronavirus_investing_right_now.jpg)
![](https://g.foolcdn.com/editorial/images/632355/one_bright_spot_for_ocugen_investors.jpg)
![](https://g.foolcdn.com/editorial/images/632351/how_risky_is_ocugen_after_its_recent_setback.jpg)
How Risky Is Ocugen After Its Recent Setback?
July 02, 2021
Via The Motley Fool
Topics
Cannabis
Exposures
Cannabis
![](https://g.foolcdn.com/editorial/images/631924/dollar-bill-being-squeezed.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.